Dr. Harshman has more than 15 years of experience in mass spectrometry based biomarker discovery. He has demonstrated expertise managing both internal and external collaborations with focuses on exhaled breath analytics/biomarker discovery and non-volatile biomarker discovery utilizing bottom-up proteomic, global metabolomic, and global lipidomic approaches. Dr. Harshman has authored or co-authored more than 15 peer-reviewed publications in the last 5 years in both biomarker discovery and molecular biology.